Login / Signup

Clinicopathologic and molecular characterization of myeloid neoplasms with isolated t(6;9)(p23;q34).

Valeria VisconteS ShettyB PrzychodzenC HirschJ BodoJ P MaciejewskiEric D HsiH J Rogers
Published in: International journal of laboratory hematology (2017)
Our data demonstrated that AML/MDS patients with t(6;9) have diverse molecular mutations regardless of the presence of FLT3 mutations, which may contribute to their poor survival outcomes.
Keyphrases